Indian CRDMOs Face Questions on Valuations and Growth Prospects

Imagine companies that help make medicines.

Right now, investors are excited about Indian companies that do this because many drug companies want to buy ingredients and have their drugs made somewhere other than China.

These Indian companies, called CRDMOs, are growing quickly and have high stock prices.

However, some experts are unsure if the prices are justified.

Despite the high growth potential and increasing interest from companies looking to diversify, investors are cautioned that their high valuations might not yet match their earnings.

These companies are also expanding to handle more work.